Cite
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.
MLA
Wang, X. Y., et al. “Preclinical Evaluation of a Prostate-Targeted Gene-Directed Enzyme Prodrug Therapy Delivered by Ovine Atadenovirus.” Gene Therapy, vol. 11, no. 21, Nov. 2004, pp. 1559–67. EBSCOhost, https://doi.org/10.1038/sj.gt.3302308.
APA
Wang, X. Y., Martiniello-Wilks, R., Shaw, J. M., Ho, T., Coulston, N., Cooke-Yarborough, C., Molloy, P. L., Cameron, F., Moghaddam, M., Lockett, T. J., Webster, L. K., Smith, I. K., Both, G. W., & Russell, P. J. (2004). Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus. Gene Therapy, 11(21), 1559–1567. https://doi.org/10.1038/sj.gt.3302308
Chicago
Wang, X Y, R Martiniello-Wilks, J M Shaw, T Ho, N Coulston, C Cooke-Yarborough, P L Molloy, et al. 2004. “Preclinical Evaluation of a Prostate-Targeted Gene-Directed Enzyme Prodrug Therapy Delivered by Ovine Atadenovirus.” Gene Therapy 11 (21): 1559–67. doi:10.1038/sj.gt.3302308.